Sleep Initiation and Maintenance Disorders Completed Phase 2 Trials for Melatonin (DB01065)

IndicationStatusPhase
DBCOND0029149 (Sleep Initiation and Maintenance Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00230737Effects of Melatonin on Insomnia Symptoms in Older AdultsTreatment